Skip to main content
SpringerLink
Log in

Neuropsychopharmacotherapy: Guidelines

  • Living reference work entry
  • First Online:
NeuroPsychopharmacotherapy

  • 235 Accesses

Abstract

Practicing evidence-based medicine (EBM) requires the ability to evaluate relevant evidence for the purpose of making an evidence-based treatment decision. The need to standardize different therapeutic approaches has encouraged the development of guidelines to advice on the treatment, management, and assessment of psychiatric conditions. Treatment guidelines serve the purpose of gathering and evaluating research data and transform them into comprehensive treatment algorithm. Based on the current status of evidence, algorithms have been combined to form a unified guideline for management. Clinical practice guidelines form the basis of standard clinical practice for all disciplines of medicine, including psychiatry. However, a significant challenge for psychiatry is the incorporation of this new knowledge into the daily work of clinicians. Moreover, there are several potential risks related with use of algorithms and guidelines. The evidence might be insufficient and the consensus panels might express biased opinions. They are often not read or followed because of poor quality or because of barriers to implementation due to either lack of agreement or ambiguity. We briefly review practice guidelines for the treatment of schizophrenia, major depression, and bipolar disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • American Psychiatric Association (APA). Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Washington, DC: APA; 2010.

    Google Scholar 

  • Amsterdam JD, Fava M, Maislin G, Rosenbaum J, Hornig-Rohan M. TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression. J Affect Disord. 1996;38(2–3):165–72.

    Article  CAS  PubMed  Google Scholar 

  • APA. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1994.

    Google Scholar 

  • APA. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association; 2013.

    Google Scholar 

  • APA. American Psychiatric Association Practice Guidelines. https://psychiatryonline.org/guidelines

  • Barnes TR. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol (Oxford, England). 2011;25(5):567–620.

    Article  CAS  Google Scholar 

  • Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Moller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry. 2013;14(5):334–85.

    Article  PubMed  Google Scholar 

  • Bauer M, Severus E, Kohler S, Whybrow PC, Angst J, Moller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 2: maintenance treatment of major depressive disorder-update 2015. World J Biol Psychiatry. 2015;16(2):76–95.

    Article  PubMed  Google Scholar 

  • Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839–42.

    Article  PubMed  PubMed Central  Google Scholar 

  • Carnett WG. Clinical practice guidelines: a tool to improve care. Qual Manag Health Care. 1999;8(1):13–21.

    Article  CAS  PubMed  Google Scholar 

  • CINP. The International College of Neuropsychopharmacology. Guidelines. https://cinp.org/Guidelines. Accessed April 2020.

  • Cleare A, Pariante CM, Young AH, Anderson IM, Christmas D, Cowen PJ, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol (Oxford, England). 2015;29(5):459–525.

    Article  CAS  Google Scholar 

  • Coleman K, Norris S, Weston A, Grimmer-Somers K, Hilier S, Merlin T, et al. NHMRC additional levels of evidence and grades for recommendations for developers of guidelines. Evidence Translation Section, and supported by National Institute of Clinical Studies Officers of the NHMRC. Australia; 2009. https://www.mja.com.au/sites/default/files/NHMRC.levels.of.evidence.2008-09.pdf. Accesed April 2020.

  • Driessen E, Van HL, Don FJ, Peen J, Kool S, Westra D, et al. The efficacy of cognitive-behavioral therapy and psychodynamic therapy in the outpatient treatment of major depression: a randomized clinical trial. Am J Psychiatry. 2013;170(9):1041–50.

    Article  PubMed  Google Scholar 

  • Driessen E, Hollon SD, Bockting CLH, Cuijpers P, Turner EH. Does publication bias inflate the apparent efficacy of psychological treatment for major depressive disorder? A systematic review and meta-analysis of US National Institutes of Health-Funded Trials. Plos One. 2015;10(9):e0137864.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Field MJ, Lohr KN. Clinical practice guidelines: directions for a new program. Washington, DC: National Academies Press 1990.

    Google Scholar 

  • Field MJ, Lohr KN, Institute of Medicine. Guidelines for clinical practice : from development to use. Washington, DC: National Academies Press; 1992.

    Google Scholar 

  • Forsner T, Hansson J, Brommels M, Wistedt AA, Forsell Y. Implementing clinical guidelines in psychiatry: a qualitative study of perceived facilitators and barriers. BMC Psychiatry. 2010;10:8.

    Article  PubMed  PubMed Central  Google Scholar 

  • Fountoulakis KN. Treatment guidelines bipolar disorder: an evidence based guide to manic depression. 2015.

    Google Scholar 

  • Fountoulakis KN, Grunze H, Vieta E, Young A, Yatham L, Blier P, et al. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines. Int J Neuropsychopharmacol. 2016a;20(2):180–95.

    PubMed Central  Google Scholar 

  • Fountoulakis KN, Yatham L, Grunze H, Vieta E, Young A, Blier P, et al. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 2: review, grading of the evidence, and a precise algorithm. Int J Neuropsychopharmacol. 2016b;20(2):121–79.

    PubMed Central  Google Scholar 

  • Fountoulakis KN, Young A, Yatham L, Grunze H, Vieta E, Blier P, et al. The International College of Neuropsychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 1: background and methods of the development of guidelines. Int J Neuropsychopharmacol. 2016c;20(2):98–120.

    PubMed Central  Google Scholar 

  • Fountoulakis KN, Vieta E, Young A, Yatham L, Grunze H, Blier P, et al. The International College of Neuropsychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 4: unmet needs in the treatment of bipolar disorder and recommendations for future research. Int J Neuropsychopharmacol. 2017;20(2):196–205.

    PubMed  Google Scholar 

  • Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Aust N Z J Psychiatry. 2016;50(5):410–72.

    Article  PubMed  Google Scholar 

  • Garnick DW, Hendricks AM, Brennan TA. Can practice guidelines reduce the number and costs of malpractice claims? JAMA. 1991;266(20):2856–60.

    Article  CAS  PubMed  Google Scholar 

  • Goodwin GM. Evidence-based guidelines for treating bipolar disorder: revised second edition – recommendations from the British Association for Psychopharmacology. J Psychopharmacol (Oxford, England). 2009;23(4):346–88.

    Article  CAS  Google Scholar 

  • Goodwin GM, Young AH. The British Association for Psychopharmacology guidelines for treatment of bipolar disorder: a summary. J Psychopharmacol (Oxford, England). 2003;17(4 Suppl):3–6.

    Google Scholar 

  • Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, et al. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol (Oxford, England). 2016;30(6):495–553.

    Article  CAS  Google Scholar 

  • Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht R, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: treatment of bipolar depression. World J Biol Psychiatry. 2002;3(3):115–24.

    Article  PubMed  Google Scholar 

  • Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht RW, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: treatment of mania. World J Biol Psychiatry. 2003;4(1):5–13.

    Article  PubMed  Google Scholar 

  • Grunze H, Kasper S, Goodwin G, Bowden C, Moller HJ. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry. 2004;5(3):120–35.

    Article  PubMed  Google Scholar 

  • Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10(2):85–116.

    Article  PubMed  Google Scholar 

  • Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010;11(2):81–109.

    Article  PubMed  Google Scholar 

  • Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry. 2013;14(3):154–219.

    Article  PubMed  Google Scholar 

  • Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Azorin JM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: acute and long-term treatment of mixed states in bipolar disorder. World J Biol Psychiatry. 2018;19(1):2–58.

    Article  PubMed  Google Scholar 

  • Hanlon P. The future public health. Maidenhead: McGraw-Hill Education; 2012.

    Google Scholar 

  • Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 2012;13(5):318–78.

    Article  PubMed  Google Scholar 

  • Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World J Biol Psychiatry. 2013;14(1):2–44.

    Article  PubMed  Google Scholar 

  • Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthøj B, Gattaz WF, et al. World Federation of Societies of biological psychiatry (WFSBP) guidelines for biological treatment of schizophrenia. Part 3: update 2015 management of special circumstances: depression, suicidality, substance use disorders and pregnancy and lactation. World J Biol Psychiatry. 2015;16(3):142–70.

    Article  PubMed  Google Scholar 

  • Hasan A, Bandelow B, Yatham LN, Berk M, Falkai P, Möller H-J, et al. WFSBP guidelines on how to grade treatment evidence for clinical guideline development. World J Biol Psychiatry. 2019;20(1):2–16.

    Article  PubMed  Google Scholar 

  • Kamens SR, Cosgrove L, Peters SM, Jones N, Flanagan E, Longden E, et al. Standards and guidelines for the development of diagnostic nomenclatures and alternatives in mental health research and practice. J Humanist Psychol. 2019;59(3):401–27.

    Article  Google Scholar 

  • Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016;61(9):540–60.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kredo T, Bernhardsson S, Machingaidze S, Young T, Louw Q, Ochodo E, et al. Guide to clinical practice guidelines: the current state of play. Int J Qual Health Care. 2016;28(1):122–8.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kusumakar V, Yatham LN, Haslam DR, Parikh SV, Matte R, Silverstone PH, et al. Treatment of mania, mixed state, and rapid cycling. Can J Psychiatr Rev can psychiatr. 1997;42(Suppl 2):79s–86s.

    Google Scholar 

  • Lam RW, McIntosh D, Wang J, Enns MW, Kolivakis T, Michalak EE, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care. Can J Psychiatry. 2016;61(9):510–23.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2 Suppl):1–56.

    PubMed  Google Scholar 

  • Leucht S, Arango C, Fleischhacker WW, Kapur S, Stroup S, van Os J, et al. CINP SCHIZOPHRENIA GUIDELINE. 2013. The International College of Neuropsychopharmacology (CINP) https://www.cinp.org/resources/Documents/CINP-schizophrenia-guideline-24.5.2013-A-C-method.pdf. Accessed April 2020.

  • MacQueen GM, Frey BN, Ismail Z, Jaworska N, Steiner M, Lieshout RJ, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 6. Special populations: youth, women, and the elderly. Can J Psychiatry. 2016;61(9):588–603.

    Article  PubMed  PubMed Central  Google Scholar 

  • Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry. 2015;49(12):1087–206.

    Article  PubMed  Google Scholar 

  • McGorry P, Killackey E, Lambert T. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry. 2005;39:1–30.

    Article  Google Scholar 

  • McIntyre JS. Usefulness and limitations of treatment guidelines in psychiatry. World Psychiatry. 2002;1(3):186–9.

    PubMed  PubMed Central  Google Scholar 

  • Milev RV, Giacobbe P, Kennedy SH, Blumberger DM, Daskalakis ZJ, Downar J, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 4. Neurostimulation treatments. Can J Psychiatry. 2016;61(9):561–75.

    Article  PubMed  PubMed Central  Google Scholar 

  • Mulrow CD. Rationale for systematic reviews. BMJ. 1994;309(6954):597–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Munder T, Brütsch O, Leonhart R, Gerger H, Barth J. Researcher allegiance in psychotherapy outcome research: an overview of reviews. Clin Psychol Rev. 2013;33(4):501–11.

    Article  PubMed  Google Scholar 

  • NICE. National Institute for Health and Care Excellence. Depression in adults: recognition and management (Clinical guideline 90). www.nice.org.uk/guidance/cg90. 2009.

  • NICE. Bipolar disorder: assessment and management clinical guideline. www.nice.org.uk/guidance/cg185. 2014

  • Nivoli G, Lorettu L, Carpiniello B, Milia P, Pinna F, Lepretti A, et al. [Charges and convictions of psychiatrists for the violent behavior of the patient: psychiatric-forensic remarks]. Riv Psichiatr. 2017;52(3):101–8.

    Google Scholar 

  • Parikh SV, Quilty LC, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. Psychological treatments. Can J Psychiatry. 2016;61(9):524–39.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 5. Complementary and alternative medicine treatments. Can J Psychiatry. 2016;61(9):576–87.

    Article  PubMed  PubMed Central  Google Scholar 

  • Remington G, Addington D, Honer W, Ismail Z, Raedler T, Teehan M. Guidelines for the pharmacotherapy of schizophrenia in adults. Can J Psychiatry. 2017;62(9):604–16.

    Article  PubMed  PubMed Central  Google Scholar 

  • Stasevic M, Karlicic IS, Divac N, Grgurevic A, Grbic I. Factors associated with adherence to guidelines of good clinical practice during hospital treatment of patients with the first episode of schizophrenia spectrum disorders. Vojnosanit Pregl. 2019;76(10):998–1006.

    Article  Google Scholar 

  • Taylor DM, Barnes TRE, Young AH. The Maudsley prescribing guidelines in psychiatry. 13th ed. India: Wiley-Blackwell; 2018.

    Google Scholar 

  • The ADAPTE process: resource toolkit for guideline adaptation. Version 2.0. http://www.g-i-n.net [Internet]. 2009.

  • Woolf SH. Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med. 1992;152(5):946–52.

    Article  CAS  PubMed  Google Scholar 

  • Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • World Federation of Societies of Biological Psychiatry (WFSBP). Treatment guidelines and consensus papers. https://www.wfsbp.org/educational-activities/wfsbp-treatment-guidelines-and-consensus-papers/

  • World Health Organisation (WHO). The ICD-10 classification of mental and behavioural disorders. Geneva: WHO; 1992.

    Google Scholar 

  • Yatham LN, Kennedy SH, O’Donovan C, Parikh S, MacQueen G, McIntyre R, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 2005;7(Suppl 3):5–69.

    Article  PubMed  Google Scholar 

  • Yatham LN, Kennedy SH, O’Donovan C, Parikh SV, MacQueen G, McIntyre RS, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord. 2006;8(6):721–39.

    Article  CAS  PubMed  Google Scholar 

  • Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O’Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11(3):225–55.

    Article  CAS  PubMed  Google Scholar 

  • Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15(1):1–44.

    Article  CAS  PubMed  Google Scholar 

  • Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Narcology, Riga Stradins University, Riga, Latvia

    Jelena Vrublevska & Lubova Renemane

Authors
  1. Jelena Vrublevska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lubova Renemane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jelena Vrublevska .

Editor information

Editors and Affiliations

  1. Dept Psychiatry , Psychosomatics & Psychotherapy, University of Würzburg, Medical School Clinical Neurochemistry, Würzburg, Germany

    Peter Riederer

  2. Inst für Psychologische Medizin, Haag, Bayern, Germany

    Gerd Laux

  3. Department of Psychiatry, University of Toronto Department of Psychiatry, Toronto, ON, Canada

    Benoit Mulsant

  4. Center Translational Res Neurol Diseases, Dalian Med Uni Shanghai Inst Health Sc Center Translational Res Neurol Diseases, Dalian, China

    Weidong Le

  5. Fujita Health University School Medicine, Toyoake, Aichi, Japan

    Toshiharu Nagatsu

Section Editor information

  1. Center of Mental Health, Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital Würzburg, Würzburg, Germany

    Peter Riederer

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Vrublevska, J., Renemane, L. (2020). Neuropsychopharmacotherapy: Guidelines. In: Riederer, P., Laux, G., Mulsant, B., Le, W., Nagatsu, T. (eds) NeuroPsychopharmacotherapy. Springer, Cham. https://doi.org/10.1007/978-3-319-56015-1_16-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56015-1_16-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56015-1

  • Online ISBN: 978-3-319-56015-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation